Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer
Immune checkpoint inhibitors (ICIs) have been successfully used for treating melanoma and non-small cell lung cancer. However, many patients with breast cancer (BC) show low response to ICIs due to the paucity of infiltrating immune cells. Pseudogenes, as a particular kind of long-chain noncoding RN...
Автори: | , , , , , , , , , , , , |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Frontiers Media S.A.
2020-08-01
|
Серія: | Frontiers in Oncology |
Предмети: | |
Онлайн доступ: | https://www.frontiersin.org/article/10.3389/fonc.2020.01245/full |